Dr. med. Sebastian Zundler

Professur für Immunzellmigration TT (Else Kröner Clinican Scientist-Professur) Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling (2021) Patankar JV, Lehmann M, Kühl AA, Atreya R, Becker C, Gonzalez-Acera M, Schmitt H, et al. Journal article Total Recall: Intestinal T-RM Cells in Health and Disease (2021) Paap EM, Müller T, Sommer K, Neurath M, Zundler S Journal article, Review article Shear Wave Dispersion Imaging for the Characterization of Focal Liver Lesions - A Pilot study (2021) Jesper D, Fiedler S, Klett D, Waldner M, Schellhaas B, Zundler S, Neurath M, Pfeifer L Journal article Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab (2021) Fischer S, Cohnen S, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Journal article Utilization of Diagnostic Imaging and Ionizing Radiation Exposure-Has the Tide Already Turned? (2020) Zundler S Journal article ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure (2020) Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Döbrönti M, Zirlik S, Fuchs F, et al. Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis (2020) Schmitt H, Ulmschneider J, Billmeier U, Scarozza P, Sonnewald S, Reid S, Atreya I, et al. Journal article, Original article IMMUNOLOGY OF IL-12: AN UPDATE ON FUNCTIONAL ACTIVITIES AND IMPLICATIONS FOR DISEASE (2020) Ullrich K, Schulze L, Paap EM, Müller T, Neurath M, Zundler S Journal article, Review article Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution